Anti-osteolytic therapy involving adiponectin

Details Anti-osteolytic therapy involving adiponectin Anti-osteolytic therapy involving adiponectin

2008-07-15

2008-07-15

Lukton, David (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S324000, C530S350000

Reexamination Certificate

active

07399742

ABSTRACT:
This invention is directed to administering an effective amount of adiponectin into an osteolytic region for treating osteolysis.

REFERENCES:
patent: 3805776 (1974-04-01), Thiele
patent: 3886948 (1975-06-01), Hakim
patent: 3924000 (1975-12-01), Thiele
patent: 4332255 (1982-06-01), Hakim et al.
patent: 4387715 (1983-06-01), Hakim et al.
patent: 4439202 (1984-03-01), Sernaker
patent: 4551128 (1985-11-01), Hakim et al.
patent: 4595390 (1986-06-01), Hakim et al.
patent: 4615691 (1986-10-01), Hakim et al.
patent: 4772257 (1988-09-01), Hakim et al.
patent: 4816016 (1989-03-01), Schulte et al.
patent: 5176627 (1993-01-01), Watson
patent: 5282864 (1994-02-01), Noiles et al.
patent: 5869330 (1999-02-01), Scherer et al.
patent: 5928182 (1999-07-01), Kraus et al.
patent: 6083912 (2000-07-01), Khouri
patent: 6083919 (2000-07-01), Johnson et al.
patent: 6328765 (2001-12-01), Hardwick et al.
patent: 6352557 (2002-03-01), Ferree
patent: 6419944 (2002-07-01), Tobinick
patent: 6503507 (2003-01-01), Allen
patent: 6527759 (2003-03-01), Tachibana et al.
patent: 6579852 (2003-06-01), Fruebis et al.
patent: 6592888 (2003-07-01), Jensen et al.
patent: 6605751 (2003-08-01), Gibbins et al.
patent: 2002/0026244 (2002-02-01), Trieu
patent: 2002/0132773 (2002-09-01), Kincade et al.
patent: 2003/0039651 (2003-02-01), Olmarker
patent: 2003/0049256 (2003-03-01), Tobinick
patent: 2003/0125679 (2003-07-01), Kubota et al.
patent: 2003/0204229 (2003-10-01), Stokes
patent: 2004/0193274 (2004-09-01), Trieu
patent: 2004/0241802 (2004-12-01), Kadowaki et al.
patent: 2005/0048644 (2005-03-01), Hedrick et al.
patent: 0990924 (2000-04-01), None
patent: 001243223 (1971-08-01), None
patent: WO 02/100387 (2002-12-01), None
patent: WO 2005/049055 (2005-06-01), None
Wolf, Anna (Biochemical and Biophysical Research Communications 323 (2) 630-5, 2004.
Yang S-Y (Gene Therapy 11 (5) 483-91, 2004).
Carmody Emily E (Arthritis and Rheumatism 46 (5) 1298-308, 2002).
Goodman Stuart (J Biomed Mater Res A, 65 (1) 43-50, 2003).
Eaton, Medicine & Health, Rhode Island 87, 201-4, 2004.
March, Medical Journal of Australia 180, S6-S10, 2004.
Carmody et al., Arthritis & Rheumatism,Viral Interleukin-10 Gene Inhibition of Inflammation, Osteoclastogenesis. . . , vol. 46(5), May 2002, pp. 1298-1308.
Goodman et al., JBMR,Modulation of Bone Ingrowth and Tissue Differentiation by Local Infusion of Interleukin-10. . . , 2002, pp. 43-50.
Hart et al., Immunology,Comparison of the Suppressive Effects of Interleukin-10 and Interleukin-4 on Synovial Fluid Macrophages. . . , 84, 1995, pp. 536-542.
Hughes et al., Rheumatology,Interleukin 10 and Arthritis, 38, 1999, pp. 293-297.
Pollice et al., J. of Orthop. Res.,Interleukin-10 Inhibits Cytokine Synthesis in Monocytes Stimulated by Titanium Particles. . . ,, vol. 16(6), 1998, pp. 697-704.
Trindade et al., Biomaterials,Interleukin-10 Inhibits Polymethylmethacrylate Particle Induced Interleukin-6. . . , 22, 2001, pp. 2067-2073.
Alini,Eur. Spine J., A Biological Approach to Treating Disc Degeneration: Not for Today, but Maybe for Tomorrow,11 (Supp. 2), 2002, pp. S215-220.
Ardehali,J. Biomed,, The Inhibitory Activity of Serum to Prevent Bacterial Adhesion is Mainly Due to Apo-transferrin, Mat, Res., Jul 1, 2003, 66, 1, pp. 21-28.
Cassatella,J. Exp. Med. Interleukin 10(IL-10)Inhibits the Release of Proinflammatroy Cytokines. . . , Dec. 1, 1993, 178(6), pp. 2207-2211.
Cassatella,J. Exp. Med., Interleukin 10(IL-10)Upregulates IL-1 Receptor Antagonist Production. . . , May 1, 1994, 179(5) pp. 1695-1699.
Desai,Anal. Biochem., Coated Microwell Plate-based Affinity Purification of Antigens, May 15, 2004, 328(2), pp. 162-165.
Diez,Eur. J. Endocrinology, The Role of the Novel Adipocyte-derived Hormone Adiponectin in Human Disease, 2003, 148, pp. 293-300.
Goupille,Spine, Matrix Metalloproteinases: The Clue to Intervertebral Disc Degeneration?, 23(14), 1998, pp. 1612-1626.
Guillen,Arthritis, Rheum., The Effects of Local Administration of Lactoferrin on Inflammation in Murine Autoimmune and Infectious Arthritis, 43, 2000, pp. 2073-2780.
Hayashida,Eur. J. Pharmacology, Lactoferrin Enhances Peripheral Opioid-mediated Antinociception via Nitric Oxide in Rats, 484, 2004, pp. 175-181.
Hayashida,J. Vet. Med. Sci., Oral Administration of Lactoferrin Inhibits Inflammation and Nociception in Rat Adjuvant-Induced Arthritis, 66(2), 2004, pp. 149-154.
Karppinen,Spine, Tumor Necrosis Factor-α Monoclonal Antibody, Infliximab, Used to Manage Severe Sciatia, 28(8), 203, pp. 750-754.
Kumada,Circulation, Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 Through Interleukin-10. . . , May 4, 2004, 109(17) pp. 2046-2049.
Matsuda,J. Biol. Chem., Role of Adiponectin in Preventing Vascular Stenosis, 277(40) pp. 37487-37491.
Motoshima,Biochem. Biophys. Res. Comm., Adiponectin Suppresses Proliferation and Superoxide Generation and Enhances eNOS Activity. . . , 2004, 315, pp. 264-172.
Nakano,J. Biochem(Tokyo), Isolation and Characterization of GBP28, a Novel Gelatin-Binding Protein Purified from Human Plazma, Oct. 1996, 120(4), pp. 803-812.
Ohko,J. Biomed. Mat. Res.(Appl Biomet), Self-Sterilizing and Self-Cleaning of Silicone Catheters Coated with TiO2Photocatalyst Thin Films: A Preclinical Work, 58, 2001, pp. 97-101.
Ouichi,Circulation, Adipocyte-derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression, . . . 103(8), Feb. 27, 2001, p. 1057.
Ouichi,Circulation, Novel Modulator for Endothelial Adhesion Molecules. . . , 1999, 100, pp. 2473-2476.
Brakenhielm,PNAS, Adiponectin-induced Antiangiogenesis and Antitumor Activity Involve Caspase-Mediated Enhothelial Cell Apoptosis, 101(8), pp. 2476-2481.
Shanbhag,J. Biomed. Mar. Res., Decreased Neutrophil Respiratory Burst on Exposure to Cobalt-Chrome alloy and Polystyrenein vitro, vol. 26, 1992, pp. 185-195.
Shimada,Clin. Chim. Actga. Adiponectin and Atheroscierotic Disease, Jun. 2004, 344(1-2), pp. 1-12.
Singh,Nature, A Component of Innate Immunity Prevents Bacterial Biofilm Development, 417, May 30, 2002, pp. 552-555.
Talukder,J. Vet. Med. Sci. Receptor-Mediated Transport of Lactoferrin into the Cerebrospinal Fluid via Plasma in Young Calves,, 65(9), 2003, pp. 957-964.
Taylor,Regul. Toxicol. Pharmacol. Safety Determination for the use of Bovine Milk-derived Lactoferrin as a Component of an Antimicrobial Beef Carcass Spray, Feb. 2004, 39(1), pp. 12-24.
Trampuz et al., Clin. Orthop,Molecular and Antibiofilm Approaches to Prosthetic Joint Infection, (414), 2003, pp. 69-88.
Trif, Exp. Biol. Med (Maywood),Liposomes as Possible Carriers for Lactoferrin in the Local Treatment of Inflammataory Diseases, 226(6), 2001, pp. 559-564.
Tobinick, Swiss Med.Weekly,Perispinal TNF-alpha Inhibition for Discogenic Pain, 2003, 133, pp. 170-177.
Wulster-Radcliffe, Biochem, Biophys. Res. Comm.,Adiponectin Differentially Regulates Cytokines in Porcine Macrophages, 316, 2004, pp. 924-929.
Yamamoto, Biochem. Biophys. Res. Comm.,Effect of Interleukin-10 on the Gene Expression of Type 1 Collagen, Fibronectin, and Decorin in Human Skin Fibroblasts: Differential Regulations by Transforming Growth Factor-β and Monocyte Chemoattractant Protein-1, 316, 2004, pp. 924-929.
Yokota,Blood, Adiponectin, a New Member of the Family of Soluble Defense Collagens, Negatively Regulates the Growth of Myelomonocytic Progenitors and the Functions of Macrophages, Sep. 1, 2000, 96(5), pp. 1723-1732.
Brennan, Rheumatology,Interleukin 10 and Arthritis, 38, 1999, pp. 293-297.
Carmody, et al., Arthritis & Rheumatism,Viral Interleukin-10 Gene Inhibition of Inflammation, . . . , 46(5), May 2002, pp. 1298-1308.
Goodman et al.,Modulation of Bone Ingrowth and Tissue Differentiation by Local Infusion of Interleukin-10. . . , JBMR, 65A, 2003, pp. 43-50.
Hart, et al., Immunology,Comparison of the Suppressive Effects of Interleukin-10 and Interleukin-4 on Synovial Fluid Macrophages. . . , 84(4), Apr. 1995, pp. 536-542.
Pollice et al., J. Orthop Res.,Interleukin-10 Inhibits Cytokine Synthesis in Monocytes Stimulated by Titanium Particles: . . . , 16(6), Nov. 1998,

Affiliated with

Also associated with

Rating

Anti-osteolytic therapy involving adiponectin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-osteolytic therapy involving adiponectin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-osteolytic therapy involving adiponectin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2765190